The launched products are Piperacillin/Tazobactam — with a unique patented manufacturing technique — and Daptomycin, which launches in Egypt for the first time.
Egyptian healthcare system achieves revolutionary progress, we are privileged to support this ongoing transformation through pivotal partnership initiatives, says Jamal Habash
The partnership is an important step in expanding access to global standard-care treatment for two of the most prevalent types of blood cancer. The newly approved antibody addresses vital patient needs, while simultaneously supporting the sustainability of the Egyptian healthcare system.
Novartis has also collaborated with the ministry to run Egypt’s first coronavirus awareness seminar in March, that brought together over 5,600 multi-specialty doctors to discuss the latest developments on the pandemic.
